ZA
SKINW

Zazove Associates’s The Beauty Health Company Warrant expiring 5/4/2026 SKINW Stock Holding History

Zazove Associates’s Portfolio SKINW Stock Details SKINW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$3.73M Buy
+258,380
New +$2.77M 0.33% 59

Other funds holding SKINW

ICM
Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
FBCM
Fort Baker Capital Management Larkspur, California $1.27B AUM 25.46% 1-Year Est. Return
KPF
K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Zazove Associates's SKINW Position: Q3 2021 in Review

Zazove Associates opened a new position in The Beauty Health Company Warrant expiring 5/4/2026 (SKINW) in Q3 2021: 258,380 shares worth $3.73M. The stake represents 0.33% of the portfolio and ranks #59 among its holdings.

31 funds tracked by Wall St. Rank hold SKINW as of Q3 2021.

  • Zazove Associates held 258,380 shares of The Beauty Health Company Warrant expiring 5/4/2026 worth $3.73M as of Q3 2021.
  • The Beauty Health Company Warrant expiring 5/4/2026 was a new Zazove Associates position in Q3 2021.
  • The Beauty Health Company Warrant expiring 5/4/2026 made up 0.33% of Zazove Associates's portfolio in Q3 2021, its #59 holding.
  • 31 funds tracked by Wall St. Rank held The Beauty Health Company Warrant expiring 5/4/2026 as of Q3 2021.

Based on Zazove Associates's 13F filing for Q3 2021, filed 25 Oct 2021.